Catalyst Wire Dossier Catalyst Wire Dossier

Acamprosate calcium enteric-coated

acamprosate calcium enteric-coated · Mylan Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Acamprosate calcium enteric-coated, covering 2014-03-11 to 2014-03-11. Get the full timeline:

Most recent: FDA Approved: ACAMPROSATE CALCIUM — Original Application (Mylan Pharmaceuticals Inc.)

See pricing